Harvey D. White, DSc, FACC

General Statement of Disclosure:

RESEARCH/RESEARCH GRANTS: National Institutes of Health (USA)(MODEST) OTHER FINANCIAL BENEFIT: Eli Lilly and Company(MODEST), AstraZeneca Pharmaceuticals(MODEST), Omthera Pharmaceuticals(SIGNIFICANT), Eisai Inc.(SIGNIFICANT), DalCor Pharma UK Inc.(SIGNIFICANT), CSL Behring LLC(SIGNIFICANT), American Regent(SIGNIFICANT), Sanofi-Aventis Australia Pty Ltd(SIGNIFICANT), Esperion Therapeutics Inc.(SIGNIFICANT), Genentech Inc(SIGNIFICANT), Sanofi Aventis(SIGNIFICANT), Novartis Corporation(MODEST), Boehringer Ingelheim Pharmaceuticals, Inc(MODEST)

View Full Disclosure